Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that Daniel Redén, a renowned horse trainer at StallZet, has entered into a partnership with Diagonal Bio and will act as a marketing partner for the Company to enhance…
Renowned horse race jockey and trainer conducts pilot test of LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that one of Sweden’s most accomplished horse race trainers, Madeleine Smith, has initiated a six-month pilot test of LAMPlify®. The pilot test will focus on enhancing…
Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces a partnership with Kolgjini Stables (Stall Kolgjini), founded by renowned harness racer Lutfi Kolgjini, to conduct a three-month pilot test. Kolgjini Stables is a Swedish stable…
Diagonal Bio announces that it is exploring financing options
English, IR, MAR, News, RegulatoryDiagonal Bio AB ("Diagonal Bio" or "the Company") today announces that the Board of Directors of the Company has engaged financial and legal advisors and decided to explore potential financing alternatives to secure the Company’s ongoing…
Diagonal announces first pilot test at a stud with LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces a partnership with Gocksta Stud (Gocksta Stuteri), led by Anne-Sophie Thiam, to conduct a three-month pilot study, which begins immediately. This pilot test will evaluate LAMPlify’s…
Diagonal Bio AB Third Quarter Report (Q3 2024)
English, Interim, IR, MAR, News, Q3, Regulatory, Report“One of the most exciting developments is our effort into a new application of our technology LAMPlify®—this time in the domain of swine diseases.”Summary of Q3 report 20242024-07-01 — 2024-09-30 (July — September…
Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces the commencement of a six-month pilot test of its point-of-care diagnostic platform, LAMPlify®, at the Norwegian University of Life Sciences (NMBU) in Ås. The pilot,…
Diagonal Bio announces successful external validation of LAMPlify® for viruses in pigs
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) (“Diagonal” or “the Company”) announces successful results of a recent pilot study conducted by the Centre for Diagnostics at DTU Health Technology. The study evaluated the performance of the LAMPlify®…
Hunneberga Horse Stable to conduct pilot test of LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that Hunneberga Horse Stable (Hunneberga Hästgård) and Tomas Hammar, showjumping trainer and CEO at Hunneberga Horse Stable, has initiated a partnership with Diagonal…
Horse trainer Daniel Redén at StallZet will conduct a pilot with LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has partnered with StallZet and Daniel Redén, one of Sweden's leading horse trotting training facilities, to conduct a pilot test using LAMPlify® to…
